Ensembl ID ENSG00000102974 Gene ID 10664 Accession 13723
Gene Symbol CTCF Alias MRD21;FAP108;CFAP108 Full Name CCCTC-binding factor
Position 16 : 67562467 - 67639177 Length 76711 bases Strand Plus strand
Status Confidence Main interacting RNAsN.A.RBP type Non-canonical_RBPs
Summary This gene is a member of the BORIS + CTCF gene family and encodes a transcriptional regulator protein with 11 highly conserved zinc finger (ZF) domains. This nuclear protein is able to use different combinations of the ZF domains to bind different DNA target sequences and proteins. Depending upon the context of the site, the protein can bind a histone acetyltransferase (HAT)-containing complex and function as a transcriptional activator or bind a histone deacetylase (HDAC)-containing complex and function as a transcriptional repressor. If the protein is bound to a transcriptional insulator element, it can block communication between enhancers and upstream promoters, thereby regulating imprinted expression. Mutations in this gene have been associated with invasive breast cancers, prostate cancers, and Wilms' tumors. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]

ENSG00000102974 Expression In 33 Tumors

Ensembl ID Gene symbol Log2 Foldchange Pvaue Cancer
ENSG00000102974 CTCF -0.2 3.82e-12 KIRC
Ensembl ID Gene symbol Cancer types Pubmed ID
ENSG00000102974 CTCF tumor 10545425
ENSG00000102974 CTCF tumour 10961925
ENSG00000102974 CTCF colorectal cancer 11120891
ENSG00000102974 CTCF Wilms' tumor 11431321
ENSG00000102974 CTCF tumor 11507042
ENSG00000102974 CTCF bladder cancer 11726548
ENSG00000102974 CTCF Tumor 11782357
ENSG00000102974 CTCF cancer 12191639
ENSG00000102974 CTCF Wilms tumors 12203779
ENSG00000102974 CTCF tumors 12538357
ENSG00000102974 CTCF tumors 12588801
ENSG00000102974 CTCF tumour 12650701
ENSG00000102974 CTCF osteosarcoma tumors 12960026
ENSG00000102974 CTCF breast cancer 14503807
ENSG00000102974 CTCF breast cancer 15084242
ENSG00000102974 CTCF breast cancer 15354217
ENSG00000102974 CTCF bladder cancer 15492815
ENSG00000102974 CTCF breast cancer 15609312
ENSG00000102974 CTCF Wilms' tumor 15743916
ENSG00000102974 CTCF tumors 15761865
ENSG00000102974 CTCF tumor 15941718
ENSG00000102974 CTCF breast cancer 15958555
ENSG00000102974 CTCF cancer 16140943
ENSG00000102974 CTCF lung cancer 16140944
ENSG00000102974 CTCF tumor 16391843
ENSG00000102974 CTCF testicular germ cell tumors 16434968
ENSG00000102974 CTCF tumour 16595548
ENSG00000102974 CTCF cancer 16647825
ENSG00000102974 CTCF cancer 16741971
ENSG00000102974 CTCF tumour 16989720
ENSG00000102974 CTCF tumours 17071074
ENSG00000102974 CTCF tumors 17082775
ENSG00000102974 CTCF lung cancer 17260018
ENSG00000102974 CTCF tumor 17267411
ENSG00000102974 CTCF tumor 17363576
ENSG00000102974 CTCF tumors 17639583
ENSG00000102974 CTCF cancer 17950379
ENSG00000102974 CTCF cancer 17962299
ENSG00000102974 CTCF cancer 18095639
ENSG00000102974 CTCF tumours 18195709
ENSG00000102974 CTCF tumour 18213475
ENSG00000102974 CTCF tumor 18348204
ENSG00000102974 CTCF tumor 18355444
ENSG00000102974 CTCF tumors 18604514
ENSG00000102974 CTCF cancer 18625744
ENSG00000102974 CTCF cancer 18769711
ENSG00000102974 CTCF tumor 19450526
ENSG00000102974 CTCF cancer 19481516
ENSG00000102974 CTCF prostate cancer 19513555
ENSG00000102974 CTCF tumor 19737964
ENSG00000102974 CTCF tumors 20051228
ENSG00000102974 CTCF cancer 20101205
ENSG00000102974 CTCF tumor 20119526
ENSG00000102974 CTCF tumor 20174815
ENSG00000102974 CTCF breast cancer 20219941
ENSG00000102974 CTCF breast cancer 20305816
ENSG00000102974 CTCF tumors 20481323
ENSG00000102974 CTCF cancer 20534141
ENSG00000102974 CTCF breast cancer 20625516
ENSG00000102974 CTCF tumors 20876690
ENSG00000102974 CTCF cancer 20877461
ENSG00000102974 CTCF cancer 21079786
ENSG00000102974 CTCF tumour 21150880
ENSG00000102974 CTCF cancer 21296871
ENSG00000102974 CTCF tumor 21304052
ENSG00000102974 CTCF lung tumors 21325284
ENSG00000102974 CTCF tumor 21465478
ENSG00000102974 CTCF breast cancer 21536749
ENSG00000102974 CTCF tumor 21663659
ENSG00000102974 CTCF cancer 21811597
ENSG00000102974 CTCF tumor 21813016
ENSG00000102974 CTCF tumor 21846316
ENSG00000102974 CTCF Cancer 21896759
ENSG00000102974 CTCF breast cancer 22142239
ENSG00000102974 CTCF cancers 22168535
ENSG00000102974 CTCF cancers 22277129
ENSG00000102974 CTCF prostate cancer 22344698
ENSG00000102974 CTCF tumor 22406832
ENSG00000102974 CTCF tumor 22615834
ENSG00000102974 CTCF Cancer 22627611
ENSG00000102974 CTCF tumour 22724006
ENSG00000102974 CTCF AMLs 22737091
ENSG00000102974 CTCF tumors 22754359
ENSG00000102974 CTCF cancer 22792300
ENSG00000102974 CTCF AML 22829791
ENSG00000102974 CTCF tumor 22879976
ENSG00000102974 CTCF tumor 22969794
ENSG00000102974 CTCF cancer 22984562
ENSG00000102974 CTCF breast cancer 23007606
ENSG00000102974 CTCF breast cancer 23056006
ENSG00000102974 CTCF tumors 23171475
ENSG00000102974 CTCF AML 23251452
ENSG00000102974 CTCF tumors 23390377
ENSG00000102974 CTCF cancer 23553099
ENSG00000102974 CTCF tumor 23620300
ENSG00000102974 CTCF breast cancer 23717195
ENSG00000102974 CTCF ovarian cancer 23745176
ENSG00000102974 CTCF tumors 23825673
ENSG00000102974 CTCF cervical cancer 23884423
ENSG00000102974 CTCF tumor 23900345
ENSG00000102974 CTCF breast cancer 23908591
ENSG00000102974 CTCF cancer 23945083
ENSG00000102974 CTCF tumors 23962719
ENSG00000102974 CTCF colon cancer 24035705
ENSG00000102974 CTCF endometrioid tumors 24071851
ENSG00000102974 CTCF cancer 24123052
ENSG00000102974 CTCF endometrial cancers 24130125
ENSG00000102974 CTCF lung cancer 24174344
ENSG00000102974 CTCF tumour 24279897
ENSG00000102974 CTCF tumor 24393203
ENSG00000102974 CTCF Wilms tumors 24534946
ENSG00000102974 CTCF tumors 24563233
ENSG00000102974 CTCF breast cancer 24649078
ENSG00000102974 CTCF cancer 24657531
ENSG00000102974 CTCF cancer 24658009
ENSG00000102974 CTCF cancers 24662484
ENSG00000102974 CTCF liver cancer 24749339
ENSG00000102974 CTCF cancer 24794443
ENSG00000102974 CTCF breast cancer 24842653
ENSG00000102974 CTCF tumor 25114808
ENSG00000102974 CTCF cancer 25238782
ENSG00000102974 CTCF lung cancer 25352953
ENSG00000102974 CTCF cancer 25469243
ENSG00000102974 CTCF endometrial cancer 25487306
ENSG00000102974 CTCF tumour 25492890
ENSG00000102974 CTCF cancer 25499215
ENSG00000102974 CTCF lung cancer 25592173
ENSG00000102974 CTCF breast cancer 25810575
ENSG00000102974 CTCF tumors 25810763
ENSG00000102974 CTCF DLBCL 25891015
ENSG00000102974 CTCF breast cancer 25962645
ENSG00000102974 CTCF cancer 26053496
ENSG00000102974 CTCF cervical cancer 26125810
ENSG00000102974 CTCF tumors 26185996
ENSG00000102974 CTCF tumor 26253137
ENSG00000102974 CTCF cancer 26268681
ENSG00000102974 CTCF cancer 26304545
ENSG00000102974 CTCF Endometrial Cancer 26330387
ENSG00000102974 CTCF liver cancer 26347501
ENSG00000102974 CTCF tumors 26412853
ENSG00000102974 CTCF tumour 26443201
ENSG00000102974 CTCF breast cancer 26478432
ENSG00000102974 CTCF tumor 26496499
ENSG00000102974 CTCF liver cancer 26513297
ENSG00000102974 CTCF cancer 26549033
ENSG00000102974 CTCF cancer 26553406
ENSG00000102974 CTCF liver cancer 26657029
ENSG00000102974 CTCF cancer 26686465
ENSG00000102974 CTCF tumors 26700815
ENSG00000102974 CTCF HNSCC 26747525
ENSG00000102974 CTCF tumor 26784546
ENSG00000102974 CTCF breast cancer 26823093
ENSG00000102974 CTCF tumor 26833217
ENSG00000102974 CTCF colon cancer 26868017
ENSG00000102974 CTCF prostate cancer 26938874
ENSG00000102974 CTCF tumour 26983574
ENSG00000102974 CTCF Cancers 27174533
ENSG00000102974 CTCF cancer 27345404
ENSG00000102974 CTCF cancer 27490693
ENSG00000102974 CTCF cancer 27542210
ENSG00000102974 CTCF tumor 27582487
ENSG00000102974 CTCF cancers 27588042
ENSG00000102974 CTCF tumor 27602765
ENSG00000102974 CTCF cancer 27632082
ENSG00000102974 CTCF breast cancer 27638884
ENSG00000102974 CTCF cancer 27669308
ENSG00000102974 CTCF tumor 27872090
ENSG00000102974 CTCF cancer 27974201
ENSG00000102974 CTCF tumour 28000771
ENSG00000102974 CTCF tumour 28056774
ENSG00000102974 CTCF cancer 28104398
ENSG00000102974 CTCF cancer 28145452
ENSG00000102974 CTCF breast cancer 28168295
ENSG00000102974 CTCF AML 28301528
ENSG00000102974 CTCF cancer 28319062
ENSG00000102974 CTCF cancer 28328845
ENSG00000102974 CTCF cancers 28408976
ENSG00000102974 CTCF tumor 28506242
ENSG00000102974 CTCF tumor 28560323
ENSG00000102974 CTCF tumour 28587163
ENSG00000102974 CTCF Cancer 28819414
ENSG00000102974 CTCF cancer 28855250
ENSG00000102974 CTCF liver cancer 28862757
ENSG00000102974 CTCF epithelial ovarian cancer 28977939
ENSG00000102974 CTCF breast cancer 29029387
ENSG00000102974 CTCF cancer 29059175
ENSG00000102974 CTCF breast cancer 29073069
ENSG00000102974 CTCF cancer 29077515
ENSG00000102974 CTCF cancers 29084850
ENSG00000102974 CTCF tumor 29142217
ENSG00000102974 CTCF breast cancer 29149895
ENSG00000102974 CTCF colon cancer 29181107
ENSG00000102974 CTCF breast cancer 29212169
ENSG00000102974 CTCF tumor 29307136
ENSG00000102974 CTCF tumor 29339716
ENSG00000102974 CTCF cancer 29354286
ENSG00000102974 CTCF tumor 29398485
ENSG00000102974 CTCF cancer 29416042
ENSG00000102974 CTCF liver cancer 29449541
ENSG00000102974 CTCF cancers 29507293
ENSG00000102974 CTCF cancer 29540241
ENSG00000102974 CTCF tumor 29549165
ENSG00000102974 CTCF cancer 29641996
ENSG00000102974 CTCF cancers 29670109
ENSG00000102974 CTCF cancer 29682202
ENSG00000102974 CTCF ovarian tumor 29802231
ENSG00000102974 CTCF liver cancer 29858084
ENSG00000102974 CTCF cancer 29860503
ENSG00000102974 CTCF tumors 29867216
ENSG00000102974 CTCF cancer 29870526
ENSG00000102974 CTCF Cancer 29898989
ENSG00000102974 CTCF prostate cancer 29956775
ENSG00000102974 CTCF cancer 30060743
ENSG00000102974 CTCF cancer 30086769
ENSG00000102974 CTCF ovarian cancer 30275357
ENSG00000102974 CTCF prostate cancer 30296942
ENSG00000102974 CTCF cancer 30323717
ENSG00000102974 CTCF tumor 30335837
ENSG00000102974 CTCF cancers 30359362
ENSG00000102974 CTCF cancers 30397315
ENSG00000102974 CTCF prostate cancer 30400943
ENSG00000102974 CTCF lung cancer 30458782
ENSG00000102974 CTCF cancers 30499053
ENSG00000102974 CTCF Cancer 30513694
ENSG00000102974 CTCF ovarian cancer 30523565
ENSG00000102974 CTCF tumors 30526646
ENSG00000102974 CTCF tumor 30575736
ENSG00000102974 CTCF cancer 30659153
ENSG00000102974 CTCF tumor 30664630
ENSG00000102974 CTCF endometrial tumors 30712080
ENSG00000102974 CTCF Wilms tumor 30718982
ENSG00000102974 CTCF cancer 30738580
ENSG00000102974 CTCF prostate cancer 30873749
ENSG00000102974 CTCF AML 30876483
ENSG00000102974 CTCF cancer 30886832
ENSG00000102974 CTCF cancer 30940740
ENSG00000102974 CTCF breast cancer 30944316
ENSG00000102974 CTCF acute myeloid leukemia (AML) 30985763
ENSG00000102974 CTCF Cancer 31078526
ENSG00000102974 CTCF cancer 31127282
ENSG00000102974 CTCF tumor 31144616
ENSG00000102974 CTCF prostate cancer 31200487
ENSG00000102974 CTCF tumor 31207151
ENSG00000102974 CTCF cancer 31221981
ENSG00000102974 CTCF cancer 31228211
ENSG00000102974 CTCF pancreatic cancer 31237042
ENSG00000102974 CTCF breast cancer 31245293
ENSG00000102974 CTCF tumour 31288858
ENSG00000102974 CTCF Ovarian Cancer 31292201
ENSG00000102974 CTCF cancer 31308741
ENSG00000102974 CTCF cancers 31340001
ENSG00000102974 CTCF breast cancer 31372638
ENSG00000102974 CTCF pancreatic cancer 31391552
ENSG00000102974 CTCF cancer 31391581
ENSG00000102974 CTCF prostate cancer 31515496
ENSG00000102974 CTCF prostate cancer 31562641
ENSG00000102974 CTCF prostate cancer 31727847
ENSG00000102974 CTCF prostate cancer 31736271
ENSG00000102974 CTCF tumor 31852961
ENSG00000102974 CTCF cancer 31945090
ENSG00000102974 CTCF breast cancer 31949157
ENSG00000102974 CTCF prostate cancer 31971633
ENSG00000102974 CTCF prostate cancers 9591631
ENSG00000102974 CTCF tumor 9756895
Ensembl ID Gene symbol Disease/phenotype Mutation type Mutated / Total samples Literature
ENSG00000102974 CTCF HER2 Positive Breast Carcinoma sequence_alteration 9.649% (11/114) 1 entry
ENSG00000102974 CTCF Endometrial Endometrioid Adenocarcinoma stop_gained 19.76% (261/1321) 4 entries
ENSG00000102974 CTCF colorectal adenocarcinoma sequence_alteration 5.308% (62/1168) 2 entries
ENSG00000102974 CTCF colorectal adenocarcinoma stop_gained 5.308% (62/1168) 2 entries
ENSG00000102974 CTCF colorectal adenocarcinoma frameshift_variant 5.308% (62/1168) 2 entries
ENSG00000102974 CTCF Endometrial Endometrioid Adenocarcinoma sequence_alteration 19.76% (261/1321) 4 entries
ENSG00000102974 CTCF colorectal adenocarcinoma missense_variant 5.308% (62/1168) 2 entries
ENSG00000102974 CTCF Endometrial Endometrioid Adenocarcinoma frameshift_variant 19.76% (261/1321) 5 entries
ENSG00000102974 CTCF Endometrial Endometrioid Adenocarcinoma missense_variant 19.76% (261/1321) 4 entries
ENSG00000102974 CTCF lung adenocarcinoma missense_variant 0.9062% (23/2538) 2 entries
ENSG00000102974 CTCF lung adenocarcinoma sequence_alteration 0.9062% (23/2538) 3 entries
ENSG00000102974 CTCF acute lymphoblastic leukemia frameshift_variant 2.491% (14/562) 1 entry
ENSG00000102974 CTCF breast phyllodes tumor sequence_alteration 2.778% (3/108) 1 entry
ENSG00000102974 CTCF breast carcinoma sequence_alteration 1.667% (29/1740) 7 entries
ENSG00000102974 CTCF Breast Carcinoma by Gene Expression Profile frameshift_variant 2.224% (28/1259) 1 entry
ENSG00000102974 CTCF Endometrial Endometrioid Adenocarcinoma stop_lost 19.76% (261/1321) 1 entry
ENSG00000102974 CTCF gastric adenocarcinoma missense_variant 1.667% (12/720) 1 entry
ENSG00000102974 CTCF bladder transitional cell carcinoma sequence_alteration 2.165% (10/462) 1 entry
ENSG00000102974 CTCF pancreatic ductal adenocarcinoma sequence_alteration 2.422% (41/1693) 2 entries
ENSG00000102974 CTCF ovarian serous adenocarcinoma missense_variant 0.6472% (6/927) 4 entries
ENSG00000102974 CTCF prostate carcinoma sequence_alteration 2.575% (12/466) 2 entries
ENSG00000102974 CTCF Breast Carcinoma by Gene Expression Profile sequence_alteration 2.224% (28/1259) 3 entries
ENSG00000102974 CTCF breast carcinoma frameshift_variant 1.667% (29/1740) 2 entries
ENSG00000102974 CTCF bladder transitional cell carcinoma frameshift_variant 2.165% (10/462) 2 entries
ENSG00000102974 CTCF melanoma missense_variant 2.069% (3/145) 3 entries
ENSG00000102974 CTCF basal cell carcinoma missense_variant 2.941% (2/68) 1 entry
ENSG00000102974 CTCF acute lymphoblastic leukemia stop_gained 2.491% (14/562) 1 entry
ENSG00000102974 CTCF brain glioblastoma sequence_alteration 0.495% (6/1212) 2 entries
ENSG00000102974 CTCF cecum adenocarcinoma missense_variant 4.545% (12/264) 1 entry
ENSG00000102974 CTCF urothelial carcinoma sequence_alteration 9.302% (8/86) 1 entry
ENSG00000102974 CTCF bladder transitional cell carcinoma missense_variant 2.165% (10/462) 2 entries
ENSG00000102974 CTCF cecum adenocarcinoma stop_gained 4.545% (12/264) 2 entries
ENSG00000102974 CTCF urothelial carcinoma stop_gained 9.302% (8/86) 1 entry
ENSG00000102974 CTCF skin melanoma missense_variant 0.5164% (6/1162) 1 entry
ENSG00000102974 CTCF breast phyllodes tumor frameshift_variant 2.778% (3/108) 1 entry
ENSG00000102974 CTCF Ovarian Endometriosis missense_variant 2.174% (2/92) 1 entry
ENSG00000102974 CTCF B-cell acute lymphoblastic leukemia missense_variant 0.5814% (2/344) 2 entries
ENSG00000102974 CTCF prostate adenocarcinoma frameshift_variant 1.668% (36/2158) 1 entry
ENSG00000102974 CTCF clear cell renal carcinoma sequence_alteration 0.3411% (5/1466) 2 entries
ENSG00000102974 CTCF cecum adenocarcinoma sequence_alteration 4.545% (12/264) 1 entry
ENSG00000102974 CTCF pancreatic ductal adenocarcinoma missense_variant 2.422% (41/1693) 1 entry
ENSG00000102974 CTCF acute myeloid leukemia stop_gained 1.618% (21/1298) 2 entries
ENSG00000102974 CTCF diffuse large B-cell lymphoma sequence_alteration 1.351% (5/370) 1 entry
ENSG00000102974 CTCF urothelial carcinoma frameshift_variant 9.302% (8/86) 1 entry
ENSG00000102974 CTCF gastric intestinal type adenocarcinoma missense_variant 10.59% (9/85) 2 entries
ENSG00000102974 CTCF Breast Carcinoma by Gene Expression Profile missense_variant 2.224% (28/1259) 3 entries
ENSG00000102974 CTCF kidney Wilms tumor missense_variant 0.5277% (2/379) 1 entry
ENSG00000102974 CTCF diffuse large B-cell lymphoma missense_variant 1.351% (5/370) 2 entries
ENSG00000102974 CTCF skin melanoma sequence_alteration 0.5164% (6/1162) 1 entry
ENSG00000102974 CTCF breast ductal adenocarcinoma sequence_alteration 3.107% (54/1738) 5 entries
ENSG00000102974 CTCF ovarian serous adenocarcinoma sequence_alteration 0.6472% (6/927) 2 entries
ENSG00000102974 CTCF acute myeloid leukemia missense_variant 1.618% (21/1298) 3 entries
ENSG00000102974 CTCF acute lymphoblastic leukemia sequence_alteration 2.491% (14/562) 1 entry
ENSG00000102974 CTCF basal cell carcinoma sequence_alteration 2.941% (2/68) 1 entry
ENSG00000102974 CTCF hepatocellular carcinoma missense_variant 1.22% (12/984) 3 entries
ENSG00000102974 CTCF breast ductal adenocarcinoma missense_variant 3.107% (54/1738) 2 entries
ENSG00000102974 CTCF bladder carcinoma missense_variant 2.317% (13/561) 1 entry
ENSG00000102974 CTCF T-cell acute lymphoblastic leukemia sequence_alteration 3.409% (27/792) 3 entries
ENSG00000102974 CTCF gastric intestinal type adenocarcinoma frameshift_variant 10.59% (9/85) 2 entries
ENSG00000102974 CTCF T-cell acute lymphoblastic leukemia missense_variant 3.409% (27/792) 2 entries
ENSG00000102974 CTCF Uterine Carcinosarcoma sequence_alteration 2.027% (3/148) 1 entry
ENSG00000102974 CTCF colon adenocarcinoma frameshift_variant 2.617% (33/1261) 3 entries
ENSG00000102974 CTCF colon adenocarcinoma stop_gained 2.617% (33/1261) 2 entries
ENSG00000102974 CTCF hepatocellular carcinoma sequence_alteration 1.22% (12/984) 2 entries
ENSG00000102974 CTCF Breast Carcinoma by Gene Expression Profile stop_gained 2.224% (28/1259) 1 entry
ENSG00000102974 CTCF T-cell acute lymphoblastic leukemia stop_gained 3.409% (27/792) 3 entries
ENSG00000102974 CTCF HER2 Positive Breast Carcinoma stop_gained 9.649% (11/114) 1 entry
ENSG00000102974 CTCF gastric adenocarcinoma frameshift_variant 1.667% (12/720) 1 entry
ENSG00000102974 CTCF gastric intestinal type adenocarcinoma sequence_alteration 10.59% (9/85) 2 entries
ENSG00000102974 CTCF small cell lung carcinoma sequence_alteration 0.6818% (3/440) 2 entries
ENSG00000102974 CTCF colon adenocarcinoma sequence_alteration 2.617% (33/1261) 3 entries
ENSG00000102974 CTCF rectal adenocarcinoma frameshift_variant 1.832% (10/546) 1 entry
ENSG00000102974 CTCF Merkel cell skin cancer sequence_alteration 3.191% (3/94) 2 entries
ENSG00000102974 CTCF female breast carcinoma sequence_alteration 2.74% (8/292) 3 entries
ENSG00000102974 CTCF Invasive Breast Carcinoma sequence_alteration 4.444% (2/45) 1 entry
ENSG00000102974 CTCF cecum adenocarcinoma frameshift_variant 4.545% (12/264) 1 entry
ENSG00000102974 CTCF central nervous system primitive neuroectodermal neoplasm sequence_alteration 0.6696% (3/448) 1 entry
ENSG00000102974 CTCF nasopharyngeal squamous cell carcinoma missense_variant 0.974% (3/308) 1 entry
ENSG00000102974 CTCF pancreatic neuroendocrine tumor missense_variant 2.542% (6/236) 1 entry
ENSG00000102974 CTCF rectal adenocarcinoma missense_variant 1.832% (10/546) 2 entries
ENSG00000102974 CTCF chronic myelomonocytic leukemia missense_variant 2.41% (2/83) 1 entry
ENSG00000102974 CTCF breast ductal adenocarcinoma frameshift_variant 3.107% (54/1738) 4 entries
ENSG00000102974 CTCF small cell lung carcinoma missense_variant 0.6818% (3/440) 2 entries
ENSG00000102974 CTCF acute myeloid leukemia sequence_alteration 1.618% (21/1298) 3 entries
ENSG00000102974 CTCF breast carcinoma missense_variant 1.667% (29/1740) 5 entries
ENSG00000102974 CTCF colon adenocarcinoma missense_variant 2.617% (33/1261) 4 entries
ENSG00000102974 CTCF small intestinal adenocarcinoma frameshift_variant 19.05% (4/21) 1 entry
ENSG00000102974 CTCF T-cell acute lymphoblastic leukemia frameshift_variant 3.409% (27/792) 3 entries
ENSG00000102974 CTCF lung adenocarcinoma stop_gained 0.9062% (23/2538) 2 entries
ENSG00000102974 CTCF gastric adenocarcinoma sequence_alteration 1.667% (12/720) 1 entry
ENSG00000102974 CTCF brain glioblastoma missense_variant 0.495% (6/1212) 2 entries
ENSG00000102974 CTCF prostate adenocarcinoma missense_variant 1.668% (36/2158) 1 entry
ENSG00000102974 CTCF urothelial carcinoma missense_variant 9.302% (8/86) 1 entry
ENSG00000102974 CTCF acute lymphoblastic leukemia missense_variant 2.491% (14/562) 3 entries
ENSG00000102974 CTCF prostate carcinoma missense_variant 2.575% (12/466) 2 entries
ENSG00000102974 CTCF female breast carcinoma missense_variant 2.74% (8/292) 3 entries
ENSG00000102974 CTCF acute myeloid leukemia frameshift_variant 1.618% (21/1298) 3 entries
ENSG00000102974 CTCF rectal adenocarcinoma sequence_alteration 1.832% (10/546) 3 entries
ENSG00000102974 CTCF prostate adenocarcinoma sequence_alteration 1.668% (36/2158) 2 entries
ENSG00000102974 CTCF chronic lymphocytic leukemia sequence_alteration 0.4489% (4/891) 1 entry
ENSG00000102974 CTCF small intestinal adenocarcinoma sequence_alteration 19.05% (4/21) 1 entry
ENSG00000102974 CTCF melanoma sequence_alteration 2.069% (3/145) 2 entries
ENSG00000102974 CTCF Merkel cell skin cancer missense_variant 3.191% (3/94) 1 entry
ENSG00000102974 CTCF Signet Ring Cell Gastric Adenocarcinoma sequence_alteration 33.33% (1/3) 1 entry
ENSG00000102974 CTCF Thyroid Gland Undifferentiated (Anaplastic) Carcinoma sequence_alteration 0.3788% (1/264) 1 entry
ENSG00000102974 CTCF medulloblastoma missense_variant 4.167% (1/24) 1 entry
ENSG00000102974 CTCF laryngeal squamous cell carcinoma missense_variant 2.439% (1/41) 1 entry
ENSG00000102974 CTCF gastric tubular adenocarcinoma frameshift_variant 50.0% (1/2) 1 entry
ENSG00000102974 CTCF myeloproliferative disorder stop_gained 2.439% (1/41) 1 entry
ENSG00000102974 CTCF anaplastic oligodendroglioma missense_variant 1.163% (1/86) 1 entry
ENSG00000102974 CTCF esophageal squamous cell carcinoma stop_gained 0.2924% (2/684) 1 entry
ENSG00000102974 CTCF endometrial carcinoma stop_gained 2.899% (2/69) 1 entry
ENSG00000102974 CTCF metaplastic breast carcinoma frameshift_variant 1.613% (1/62) 1 entry
ENSG00000102974 CTCF leiomyosarcoma sequence_alteration 0.9901% (1/101) 1 entry
ENSG00000102974 CTCF brain glioblastoma frameshift_variant 0.495% (6/1212) 1 entry
ENSG00000102974 CTCF undifferentiated pleomorphic sarcoma missense_variant 1.613% (1/62) 1 entry
ENSG00000102974 CTCF Gallbladder Adenocarcinoma missense_variant 0.7143% (1/140) 1 entry
ENSG00000102974 CTCF Hodgkins lymphoma frameshift_variant 10.0% (1/10) 1 entry
ENSG00000102974 CTCF Appendix Adenocarcinoma stop_gained 1.351% (1/74) 1 entry
ENSG00000102974 CTCF T-cell acute lymphoblastic leukemia amino_acid_insertion 3.409% (27/792) 1 entry
ENSG00000102974 CTCF B-cell neoplasm missense_variant 5.556% (1/18) 1 entry
ENSG00000102974 CTCF Pleural Epithelioid Mesothelioma sequence_alteration 0.5% (1/200) 1 entry
ENSG00000102974 CTCF Ovarian Endometriosis sequence_alteration 2.174% (2/92) 1 entry
ENSG00000102974 CTCF myelodysplastic syndrome missense_variant 0.6944% (1/144) 1 entry
ENSG00000102974 CTCF Bladder Adenocarcinoma missense_variant 14.29% (1/7) 1 entry
ENSG00000102974 CTCF breast ductal adenocarcinoma stop_gained 3.107% (54/1738) 1 entry
ENSG00000102974 CTCF female breast carcinoma frameshift_variant 2.74% (8/292) 1 entry
ENSG00000102974 CTCF Signet Ring Cell Gastric Adenocarcinoma frameshift_variant 33.33% (1/3) 1 entry
ENSG00000102974 CTCF hepatocellular carcinoma frameshift_variant 1.22% (12/984) 1 entry
ENSG00000102974 CTCF bile duct adenocarcinoma missense_variant 0.2558% (1/391) 1 entry
ENSG00000102974 CTCF Thyroid Gland Undifferentiated (Anaplastic) Carcinoma stop_gained 0.3788% (1/264) 1 entry
ENSG00000102974 CTCF chronic myelogenous leukemia missense_variant 3.704% (1/27) 1 entry
ENSG00000102974 CTCF Breast Carcinoma by Gene Expression Profile conservative_inframe_deletion 2.224% (28/1259) 1 entry
ENSG00000102974 CTCF pancreatic ductal adenocarcinoma frameshift_variant 2.422% (41/1693) 1 entry
ENSG00000102974 CTCF Invasive Breast Carcinoma conservative_inframe_deletion 4.444% (2/45) 1 entry
ENSG00000102974 CTCF myeloproliferative disorder sequence_alteration 2.439% (1/41) 1 entry
ENSG00000102974 CTCF nasopharyngeal squamous cell carcinoma frameshift_variant 0.974% (3/308) 1 entry
ENSG00000102974 CTCF Invasive Breast Carcinoma missense_variant 4.444% (2/45) 1 entry
ENSG00000102974 CTCF lobular breast carcinoma missense_variant 1.087% (3/276) 1 entry
ENSG00000102974 CTCF skin melanoma stop_gained 0.5164% (6/1162) 1 entry
ENSG00000102974 CTCF acute lymphoblastic leukemia conservative_inframe_deletion 2.491% (14/562) 1 entry
ENSG00000102974 CTCF bladder transitional cell carcinoma stop_gained 2.165% (10/462) 1 entry
ENSG00000102974 CTCF gastric tubular adenocarcinoma sequence_alteration 50.0% (1/2) 1 entry
ENSG00000102974 CTCF Uterine Carcinosarcoma missense_variant 2.027% (3/148) 1 entry
ENSG00000102974 CTCF Endometrial Undifferentiated Carcinoma frameshift_variant 33.33% (1/3) 1 entry
ENSG00000102974 CTCF esophageal adenocarcinoma missense_variant 2.555% (14/548) 1 entry
ENSG00000102974 CTCF breast phyllodes tumor missense_variant 2.778% (3/108) 1 entry
ENSG00000102974 CTCF breast carcinoma conservative_inframe_deletion 1.667% (29/1740) 1 entry
ENSG00000102974 CTCF oral squamous cell carcinoma missense_variant 0.3802% (1/263) 1 entry
ENSG00000102974 CTCF endometrial carcinoma missense_variant 2.899% (2/69) 1 entry
ENSG00000102974 CTCF endometrial carcinoma sequence_alteration 2.899% (2/69) 1 entry
ENSG00000102974 CTCF Appendix Adenocarcinoma sequence_alteration 1.351% (1/74) 1 entry
ENSG00000102974 CTCF angioimmunoblastic T-cell lymphoma missense_variant 0.9346% (1/107) 1 entry
ENSG00000102974 CTCF myelodysplastic syndrome sequence_alteration 0.6944% (1/144) 1 entry
ENSG00000102974 CTCF nasal cavity and paranasal sinus carcinoma missense_variant 16.67% (1/6) 1 entry
ENSG00000102974 CTCF diffuse large B-cell lymphoma stop_gained 1.351% (5/370) 1 entry
ENSG00000102974 CTCF Pleural Epithelioid Mesothelioma missense_variant 0.5% (1/200) 1 entry
ENSG00000102974 CTCF Merkel cell skin cancer stop_gained 3.191% (3/94) 1 entry
ENSG00000102974 CTCF salivary gland adenoid cystic carcinoma missense_variant 1.587% (1/63) 1 entry
ENSG00000102974 CTCF leiomyosarcoma frameshift_variant 0.9901% (1/101) 1 entry
ENSG00000102974 CTCF Hidradenocarcinoma missense_variant 50.0% (1/2) 1 entry
Ensembl ID Gene symbol Cancer P-value Which worse show
ENSG00000102974 CTCF SARC 0.037 high
ENSG00000102974 CTCF UVM 0.021 low
ENSG00000102974 CTCF PAAD 0.012 high
ENSG00000102974 CTCF UCEC 0.041 low
ENSG00000102974 CTCF THCA 0.048 high
ENSG00000102974 CTCF ACC 0.031 high
ENSG00000102974 CTCF LUSC 0.0077 high
ENSG00000102974 CTCF THYM 0.0015 low
ENSG00000102974 CTCF ESCA 0.00044 high
ENSG00000102974 CTCF PRAD 0.013 high
ENSG00000102974 CTCF BLCA 0.047 low
ENSG00000102974 CTCF GBM 0.023 low
ENSG00000102974 CTCF LIHC 0.00093 high
Ensembl ID Gene symbol Cancer CNV type -log10(q-value) G-score average amplitude frequency
ENSG00000102974 CTCF LAML Del 2.171916 0.050448 0.627555 0.041885
ENSG00000102974 CTCF ACC Amp 1.189809 0.311855 1.038712 0.622222
ENSG00000102974 CTCF TGCT Amp 1.448869 0.152317 0.674575 0.140000
ENSG00000102974 CTCF UCEC Del 5.108089 0.089384 0.621476 0.298701
ENSG00000102974 CTCF OV Del 10.266297 0.302544 0.657843 0.789292